A Candid Assessment of the Link between Oral Candida Containing Biofilms and Oral Cancer

An association between Candida and oral cancer has long been discussed in the literature and in particular Candida albicans has been proposed to play a significant role in the development of oral cancer. Although this organism is a common member of the oral mucosa and can cause a variety of oral mucosal lesions, the exact mechanisms by which C. albicans potentially causes the development of malignant disease still require much research. We have undertaken an extensive literature search to understand pathogenicity of C. albicans, including its virulence factors, its interactions with the host immune, how a dysregulation of the immune response can result in malignancy, and how a potential C. albicans specific cytokine response may be involved in oral carcinogenesis. We present here a candid assessment of the role of Candida in oral carcinogenesis and a hypothetical model about how this may occur. Finally, we present potential future research which is necessary to elucidate this role.

[1]  C. Hill,et al.  Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. , 2006, Cytokine & growth factor reviews.

[2]  D. Soll,et al.  Unique phenotype of opaque cells in the white-opaque transition of Candida albicans , 1987, Journal of bacteriology.

[3]  L. Samaranayake,et al.  In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. , 2007, Archives of oral biology.

[4]  D. Williamson.  CHRONIC HYPERPLASTIC CANDIDIASIS AND SQUAMOUS CARCINOMA , 1969, The British journal of dermatology.

[5]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[6]  A. Aggarwal,et al.  NF-kB transcription factor: a key player in the generation of immune response , 2006 .

[7]  R. Calderone,et al.  Adherence and receptor relationships of Candida albicans. , 1991, Microbiological reviews.

[8]  Brian Bierie,et al.  TGF- and cancer , 2006 .

[9]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[10]  E. K. Parkinson,et al.  Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion , 2014, British Journal of Cancer.

[11]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[12]  Marina Mohd Bakri,et al.  Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma , 2010, Journal of oral microbiology.

[13]  Keith T. Wilson,et al.  Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.

[14]  J. Schneider,et al.  Cross-reactivity between Candida albicans and oral squamous cell carcinoma revealed by monoclonal antibody C7. , 2007, Anticancer research.

[15]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[16]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[17]  G. Liguori,et al.  Candida spp. in oral cancer and oral precancerous lesions. , 2013, The new microbiologica.

[18]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  M. De la Fuente,et al.  Chronic Inflammation and Cytokines in the Tumor Microenvironment , 2014, Journal of immunology research.

[20]  P. Speight,et al.  Oral yeast carriage correlates with presence of oral epithelial dysplasia. , 2002, Oral oncology.

[21]  E. Fuchs,et al.  Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. , 2007, Cancer cell.

[22]  Mohd Hafiz Arzmi,et al.  Gaining More Insight into the Determinants of Candida Species Pathogenicity in the Oral Cavity , 2014 .

[23]  Duncan W. Wilson,et al.  Candida albicans pathogenicity mechanisms , 2013, Virulence.

[24]  R. Morgan,et al.  Oral candidiasis , 2002, Postgraduate medical journal.

[25]  G. Sethi,et al.  Analysis of the intricate relationship between chronic inflammation and cancer. , 2015, The Biochemical journal.

[26]  S. Reed,et al.  TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. , 1995, Journal of immunology.

[27]  David W Williams,et al.  Pathogenesis and treatment of oral candidosis , 2011, Journal of oral microbiology.

[28]  J. Berman,et al.  The distinct morphogenic states of Candida albicans. , 2004, Trends in microbiology.

[29]  K. Wilhelmus,et al.  Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis. , 2007, Investigative ophthalmology & visual science.

[30]  K. Hazen.  Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells , 1989, Infection and immunity.

[31]  S. Gokul,et al.  Candida in oral pre-cancer and oral cancer. , 2011, Medical hypotheses.

[32]  Marie-Adèle Rajandream,et al.  Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. , 2009, Genome research.

[33]  P. Hunter,et al.  Increased phenotypic switching in strains of Candida albicans associated with invasive infections , 1994, Journal of clinical microbiology.

[34]  D. Moyes,et al.  Mucosal Immunity and Candida albicans Infection , 2011, Clinical & developmental immunology.

[35]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[36]  E. Reynolds,et al.  Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms. , 2013, FEMS yeast research.

[37]  L. Samaranayake,et al.  Factors affecting th in-vitro adherence of Candida albicans to acrylic surfaces. , 1980, Archives of oral biology.

[38]  H. Newman,et al.  The microflora associated with human oral carcinomas. , 1998, Oral oncology.

[39]  Dong-Han Chen,et al.  Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications , 2012, Journal of experimental & clinical cancer research : CR.

[40]  Xavier Matias-Guiu,et al.  NF-kB in development and progression of human cancer , 2005, Virchows Archiv.

[41]  C. Scully,et al.  Candida and oral candidosis: a review. , 1994, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[42]  J. Reibel.  Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. , 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[43]  M. Rouabhia,et al.  Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[44]  R. Cawson,et al.  Leukoplakia and Oral Cancer , 1969, Proceedings of the Royal Society of Medicine.

[45]  K. Kavanagh,et al.  Adherence mechanisms of Candida albicans. , 2000, British journal of biomedical science.

[46]  H. Jenkinson,et al.  Interactions between Candida Species and Bacteria in Mixed Infections , 2002 .

[47]  S. Franceschi,et al.  Oral hygiene, dentition, sexual habits and risk of oral cancer , 2000, British Journal of Cancer.

[48]  I. Thompson,et al.  Cancer Incidence and Mortality , 2013 .

[49]  K. Hojo,et al.  Bacterial Interactions in Dental Biofilm Development , 2009, Journal of dental research.

[50]  B. Hube,et al.  Candida albicans proteinases and host/pathogen interactions , 2004, Cellular microbiology.

[51]  E. Reynolds,et al.  Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. , 2015, Oral oncology.

[52]  S. Lanka.  CHRONIC HYPERPLASTIC CANDIDOSIS/CANDIDIASIS (CANDIDAL LEUKOPLAKIA) , 2003 .

[53]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[54]  H. Sørensen,et al.  Candida infection and cancer risk: a Danish nationwide cohort study. , 2013, European journal of internal medicine.

[55]  S. Gaffen,et al.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis , 2009, The Journal of experimental medicine.

[56]  S. Gaffen,et al.  Brothers in Arms: Th17 and Treg Responses in Candida albicans Immunity , 2014, PLoS pathogens.

[57]  R. Srikantha,et al.  Candida albicans switch phenotypes display differential levels of fitness. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[58]  S. Challacombe,et al.  A Biphasic Innate Immune MAPK Response Discriminates between the Yeast and Hyphal Forms of Candida albicans in Epithelial Cells , 2010, Cell host & microbe.

[59]  P. Krogh.  The role of yeasts in oral cancer by means of endogenous nitrosation. , 1990, Acta odontologica Scandinavica.